Haegarda

Takeda, CSL hereditary angioedema meds need steep discounts following real-world evidence review, ICER says
Fierce Pharma
Wed, 08/25/21 - 09:32 pm
Takeda
CSL
hereditary angiodema
HAE
RWE
Takhzyro
Cinryze
Haegarda
Shire scores new FDA thumbs-up for HAE drug Cinryze in latest bid to fend off rival CSL
Fierce Pharma
Thu, 06/21/18 - 12:02 pm
CSL
HAE
Shire
Cinryze
Haegarda
FDA OKs CSL’s new HAE drug, already embroiled in a blockbuster fight with Shire
Endpoints
Fri, 06/23/17 - 09:48 am
FDA
CSL
HAE
hereditary angiodema
Shire
Haegarda
Firazyr
Kalbito
Shire, armed with new rare disease patent, aims to block CSL's Haegarda launch
Fierce Pharma
Mon, 04/17/17 - 04:10 pm
Shire
rare disease
CSL
patents
Haegarda
HAE
hereditary angiodema